IPCA Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 6 per equity share.
IPCALAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
IPCA Laboratories Board has recommended a final dividend of Rs. 6 per equity share (600% on face value of Re. 1) for FY 2025-26, subject to shareholder approval at the ensuing AGM. The record date for dividend entitlement is August 7, 2026. The company reported robust standalone revenue of Rs. 7,336.75 crore (up 9.9% YoY) and consolidated revenue of Rs. 9,646.33 crore (up 7.9% YoY). Standalone profit after tax surged 74% to Rs. 1,132.52 crore, while consolidated PAT rose 55% to Rs. 1,141.12 crore. EPS improved significantly to Rs. 44.64 on standalone basis. Exceptional items included Rs. 30.42 crore impact from new Labour Codes and Rs. 281.54 crore in impairments. The Board also re-appointed Mr. Prashant Godha as Executive Director for 5 years.
The company demonstrates strong financial growth with 74% jump in standalone PAT, indicating improved operational efficiency. The dividend of Rs. 6 per share signals confidence in sustained profitability, though the exact yield depends on current market price. Shareholders can expect dividend payout post-AGM approval.